Notice Number: NOT-EY-18-003

Key Dates
Release Date: December 21, 2017

Issued by
National Eye Institute (NEI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Eye Institute (NEI) will participate, effective immediately, in PAR-18-501, "BRAIN Initiative: Development, Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR)(R43/R44 Clinical Trial Not Allowed)".

The following sections of PAR-18-501 (shown in italics) have been updated to reflect the participation of the NEI in this Funding Opportunity Announcement (FOA).

Part 1. Overview Information

Components of Participating Organizations
National Eye Institute (NEI)
National Institute of Mental Health (NIMH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute on Drug Abuse (NIDA)
National Institute of Neurological Disorders and Stroke (NINDS)
National Center for Complementary and Integrative Health (NCCIH)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.242, 93.865, 93.273, 93.279, 93.853, 93.173, 93.213, 93.286, 93.867

Section VII. Agency Contacts

Scientific/Research Contact(s) 
Martha Flanders, PhD
National Eye Institute (NEI)
Telephone: 301-451-2020
Email: [email protected]

Financial/Grants Management Contact(s) 
Karen Robinson Smith
National Eye Institute (NEI)
Telephone: 301-451-2020
[email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Martha Flanders, PhD
National Eye Institute (NEI)
Telephone: 301-451-2020
Email: [email protected]